TITLE

AGENIX SUCCESSFULLY COMPLETES PHASE IA BLOOD CLOT TRIAL

PUB. DATE
August 2003
SOURCE
Worldwide Biotech;Aug2003, Vol. 15 Issue 8, p5
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the completion of patient-treatment component of phase Ia trial for ThromboView, a blood clot-detection technology of Agenix Limited.
ACCESSION #
10400340

 

Related Articles

  • Former Pfizer Worldwide Business Development Director Joins Australian Drug Development Company Agenix.  // Biomedical Market Newsletter;6/7/2012, Vol. 21, p1 

    The article announces that Agenix Ltd has appointed Paul Resnick as the business advisor.

  • AGENIX FIRST QUARTER REVENUE UP 55%.  // Biotech Financial Reports;Dec2001, p1 

    Reports the increased first quarter revenue of Agenix Limited in Australia. Introduction of additional products; Investment in the Thromboview program; Rise in international sales.

  • STOCK.  // Australasian Biotechnology;Feb2011, Vol. 21 Issue 1, p39 

    A chart is presented that lists the performance of biotechnology firms listed in the Australia Securities Exchange which includes Agenix Limited, Apollo Consolidated Limited, and Ascent Pharmahealth Ltd.

  • Corporate, institute and associate members of AusBiotech.  // Australasian Biotechnology;Oct2013, Vol. 23 Issue 3, p68 

    The article lists the corporate, institute and associate members of Australia's Biotechnology Organization (AusBiotech) including Agenix Ltd., Acrux Ltd., and Avatar Corp. Pty. Ltd.

  • AUSTRALIA BIOTECHNOLOGY.  // Acquisdata Industry SnapShot: Australia Biotechnology;11/5/2015, Issue 3695, preceding p1 

    The article presents an overview of the biotechnology industry of Australia for 2015 which includes firms like Acrux Ltd., Agenix Ltd., and Avexa Ltd.

  • AUSTRALIA BIOTECHNOLOGY.  // Acquisdata Industry SnapShot: Australia Biotechnology;6/26/2015, Issue 2974, p1 

    An industry report of the biotechnology industry in Australia is presented from publisher Acquisdata Pty. Ltd., with topics including industry news, research on differences between strategic alliances and individual scientific collaborations, and leading firms in the industry including Agenix Ltd.

  • AUSTRALIA BIOTECHNOLOGY.  // Acquisdata Industry SnapShot: Australia Biotechnology;7/7/2015, Issue 3025, preceding p1 

    An industry report of the biotechnology industry in Australia is presented from publisher Acquisdata Pty. Ltd., with topics including industry news, research on the use of phenomics and genomics in analyzing nitrogen assimilation of a fungus, and leading firms in the industry including Agenix Ltd.

  • INVESTIGATING THE EFFECTS OF ASPIRIN ON BLOOD CLOT STRUCTURE USING A NOVEL CELLULAR IN-VITRO SYSTEM.  // Heart;Jul2008 Supp, Vol. 94, pA135 

    An abstract of the article "Investigating the Effects of Aspirin on Blood Clot Structure Using a Novel Cellular In-Vitro System," by R. A. Ajjan and colleagues is presented.

  • Thrombosis: Theoretical considerations. Mann, Kenneth G. // American Journal of Clinical Nutrition;May97 Supplement, Vol. 65, p1657S 

    Presents concise descriptions on the four steps in the blood coagulation process. Initiation of the process in response to vascular injury; Propagation; Constitutive and reactive termination reactions of the process; Elimination; Repair; Integration of the processes at a conceptual level; Lipid...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics